MedPharm - 2025 Company Profile, Funding & Competitors

Q: Where is MedPharm located?

MedPharm is located in Guildford, United Kingdom .

MedPharm is a late stage company based in Guildford (United Kingdom), founded in 1998 by and . It operates as a Developer and manufacturer of API and pharmaceutical formulations. MedPharm has raised an undisclosed amount in funding. The company has 842 active competitors, including 31 funded and 125 that have exited. Its top competitors include companies like Akums, Jubilant Life Sciences and Unither.

Company Details

MedPharm is focused on topical and inhaled drug delivery methods. They have developed MedSpray, which is a spray-on topical or mucosal drug delivery mechanism, that sprays the drug on the skin or mucous membranes via an aerosol spray can produce an invisible film. This has aesthetic advantages (thus increases drug compliance) while being a sustained/extended delivery mechanism. The other drug delivery mechanisms include MedTherm (thermogenic transdermal formulation) and AquaRMed (hygroscopic, synthetic humectant to increase bioavailability). They also provide development services in areas such as development Process, formulation development, performance testing, manufacture of clinical supplies, routes of delivery.

Website
Social
Email ID: @medpharm.com
Phone Number: +44

Key Metrics

Founded Year

1998

Location

Guildford, United Kingdom

Stage

Late Stage

Latest Funding Round

Investors

Ampersand Capital

Ranked

16^th among 842 active competitors

Annual Revenue

as on Dec 31, 2021

Employee Count

as on Dec 31, 2021

Similar Companies

Akums &

Legal entities associated with MedPharm

MedPharm is associated with 4 legal entities given below:

Legal Entity Name	Date of incorporation	Revenue	Net Profit	Employee Count
	Jul 06, 2012	$2.41M (as on Dec 31, 2022)	129	338
MEDPHARM HOLDCO LIMITED		-	568	412
MEDPHARM LIMITED	Jun 06, 1999	$26.7M (as on Dec 31, 2021)	781	742
	Dec 31, 1999	-	582	728

MedPharm has raised funding over 1 round. Its latest funding round was a PE round on Mar 26, 2018 for an undisclosed amount. 1 investor participated in its latest round, which include Ampersand Capital.

MedPharm has 1 institutional investor - Ampersand Capital.

Here is the list of recent funding rounds of MedPharm:

Date of funding	Funding Amount	Round Name	Post money valuation	Revenue multiple	Investors
Mar 26, 2018	Undisclosed	PE	4117975	5209956	Ampersand Capital

Access funding benchmarks and valuations. Sign up today!

View details of MedPharm's funding rounds and investors

The founders of MedPharm are and . is the CEO of MedPharm.

View details of MedPharm's Founder profiles and Board Members

MedPharm's employee count trend

MedPharm has 108 employees as of Dec 21. The total employee count is 2.9% more than what it was in Dec 20. Here is MedPharm's employee count trend over the years:

Uncover MedPharm's growth story! Sign up today!

Top competitors of MedPharm include Akums, Jubilant Life Sciences and Unither. Here is the list of Top 10 competitors of MedPharm, ranked by 秘密研究所 score :

Overall Rank	Company Details	Short Description	Total Funding	Investors	秘密研究所 Score
1st	Akums 2004, Delhi (India), Public	CDMO focusing on spectrum of dosage forms and therapeutic segments	$70M	Quadria Capital听&补尘辫;听	64/100
2nd	Jubilant Life Sciences 1978, Noida (India), Public	Company offering a suite of R&D and manufacturing services for small molecules and generics	-	General Atlantic, Samena Capital	62/100
3rd	Unither 1993, Paris (France), Acquired	Contract development and manufacturing organization for proprietary and generic drugs	-	Picardie Investissement, Parquest听&补尘辫;听	61/100
4th	Recipharm 1995, Jordbro (Sweden), Acquired	Contract services for pharmaceutical development and manufacturing	-	Ampersand Capital, CPP Investments	59/100
5th	Maiva Pharma 1996, Hosur (India), Late Stage	Manufacturer of formulation development, analytical method validation, and inject able supply services	$125M	Komaf, 听&补尘辫;听	58/100
6th	Nectar Lifesciences 1995, Chandigarh (India), Public	Manufacturer of cephalosporin APIs and generic formulations	$46.9M	Vedanta Capital, EQ India Advisors听&补尘辫;听	58/100
7th	Rubicon 2000, Mumbai (India), Acquired	CDMO offering drug development services through its proprietary drug delivery technologies	$4.62M	Terentia, Kotak Mahindra Bank听&补尘辫;听	57/100
8th	Windlas 2001, Gurugram (India), Public	Provider of regulatory affair, quality control, and market strategy services to biopharma sector	$13M	Tano Capital, IndusInd Bank听&补尘辫;听	57/100
9th	Kezzler 2001, Oslo (Norway), Series A	Mass serialization solutions for a wide range of industries	$17.7M	VestLand, DNV听&补尘辫;听	55/100
10th	CoreRx 2006, Clearwater (United States), Acquired	CDMO with a focus on early phase drug product development	$15M	QHP Capital, 听&补尘辫;听	55/100
16th	1998, Guildford (United Kingdom), Late Stage	Developer and manufacturer of API and pharmaceutical formulations	-	Ampersand Capital	51/100